Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merck & Co Inc MRK

Healthcare
Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for... see more

Recent & Breaking News (NYSE:MRK)

The Real Story Behind EMC, MRK, VZ and FB

Marketwired March 21, 2013

Were You in Early on MRK, KRFT, EMC and ULTA

Marketwired March 18, 2013

Improving Lives: Breakthroughs & Collaborations - Research Report on Pfizer, Merck, Bristol-Myers Squibb, J&J and Lilly

PR Newswire March 18, 2013

Special Situation Coming Soon, a Look Inside XOM, MRK, HD and AMZN

Marketwired March 15, 2013

Free Research Reports on BIOS, GLUU, MLNX and MRK Issued by the Bedford Report

Marketwired March 13, 2013

Merck and Luminex Corporation Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE inhibitor Clinical Development Program for Alzheimer's Disease

Business Wire March 13, 2013

Dividends From the Dow 30 Reach Highest Level Since Before the Financial Crisis

Marketwired March 13, 2013

A Forward Look, The Year Ahead - Research Report on United Continental Holdings Inc., Abbott Laboratories, Merck & Co., Inc., Dell Inc. and Microsoft Corporation

PR Newswire March 13, 2013

Drug Stock Watch List Announced (NYSE:MRK) and (NYSE:PFE) added

Accesswire March 13, 2013

The Straight Truth, Investing in MRK, PCLN, BP and HON

Marketwired March 12, 2013

Merck Provides Update on IMPROVE-IT Trial

Business Wire March 12, 2013

StockCall Study on Merck & Co., Pfizer, Johnson & Johnson, and AbbVie

PR Newswire March 12, 2013

Secrets to Making Money in JNJ, MRK and QCOM

Marketwired March 11, 2013

Results from HPS2-THRIVE Study of TREDAPTIVE(TM) (extended-release niacin/laropiprant) Presented at American College of Cardiology Scientific Sessions

Business Wire March 9, 2013

The Reason It Trades, What's Moving PFE, QCOM, JNJ and MRK

Marketwired March 8, 2013

Strategy Behind Our Success, We Get in Early: VOD, MRK and EBAY

Marketwired March 7, 2013

Aggressive R&D Initiatives and Innovative Pipelines - Research Report on J&J, Merck, AbbVie, Novartis, and GSK

PR Newswire March 7, 2013

Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire

Business Wire March 7, 2013

Before the Crowd, How we Found WMT, GILD, MRK and COF

Marketwired March 6, 2013

Merck to Present at the 33rd Annual Cowen Health Care Conference

Business Wire March 5, 2013